Suppr超能文献

睡眠呼吸暂停与青光眼和年龄相关性黄斑变性的关联:英国生物库和加拿大老龄化纵向研究的分析。

Associations of sleep apnoea with glaucoma and age-related macular degeneration: an analysis in the United Kingdom Biobank and the Canadian Longitudinal Study on Aging.

机构信息

Statistical Genetics, QIMR Berghofer Medical Research Institute, 300 Herston Road, Brisbane, Queensland, 4006, Australia.

School of Medicine, University of Queensland, Brisbane, Australia.

出版信息

BMC Med. 2021 May 11;19(1):104. doi: 10.1186/s12916-021-01973-y.

Abstract

BACKGROUND

Sleep apnoea, a common sleep-disordered breathing condition, is characterised by upper airway collapse during sleep resulting in transient hypoxia, hypoperfusion of the optic nerve, and spike in intracranial pressure. Previous studies have reported conflicting findings on the association of sleep apnoea with glaucoma, and there are limited reports on the link between sleep apnoea and age-related macular degeneration (AMD).

METHODS

Middle-aged and older participants from the longitudinal United Kingdom (UK) Biobank (n = 502,505) and the Canadian Longitudinal Study on Aging (CLSA; n = 24,073) were included in this analysis. Participants in the UK Biobank and the CLSA were followed for 8 and 3 years, respectively. Participants with diagnosed glaucoma or AMD at baseline were excluded from the analysis. In the UK Biobank, sleep apnoea and incident cases of glaucoma and AMD were identified through hospital inpatient admission, primary care records, and self-reported data. Multivariable Cox proportional hazards models were used to explore associations of sleep apnoea with incidence of glaucoma or AMD.

RESULTS

During the 8-year follow-up in the UK Biobank, glaucoma incidence rates per 1000 person-years were 2.46 and 1.59 for participants with and without sleep apnoea, and the AMD incidence rates per 1000 person-years were 2.27 and 1.42 for participants with and without sleep apnoea, respectively. Multivariable adjusted hazard ratios of glaucoma and AMD risk for sleep apnoea were 1.33 (95% confidence interval [CI] 1.10-1.60, P = 0.003) and 1.39 (95% CI 1.15-1.68, P <  0.001) relative to participants without sleep apnoea. In the CLSA cohort, disease information was collected through in-person interview questionnaires. During the 3-year follow-up, glaucoma incidence rates per 1000 person-years for those with and without sleep apnoea were 9.31 and 6.97, and the AMD incidence rates per 1000 person-years were 8.44 and 6.67, respectively. In the CLSA, similar associations were identified, with glaucoma and AMD odds ratios of 1.43 (95% CI 1.13-1.79) and 1.39 (95% CI 1.08-1.77), respectively, in participants with sleep apnoea compared to those without sleep apnoea (both P <  0.001).

CONCLUSIONS

In two large-scale prospective cohort studies, sleep apnoea is associated with a higher risk of both glaucoma and AMD. These findings indicate that patients with sleep apnoea might benefit from regular ophthalmologic examinations.

摘要

背景

睡眠呼吸暂停是一种常见的睡眠呼吸紊乱疾病,其特征是睡眠期间上呼吸道塌陷,导致短暂性缺氧、视神经灌注不足和颅内压升高。先前的研究报告了睡眠呼吸暂停与青光眼之间关联的相互矛盾的结果,并且关于睡眠呼吸暂停与年龄相关性黄斑变性(AMD)之间的联系的报告有限。

方法

本分析纳入了来自纵向英国生物库(n=502505)和加拿大老龄化纵向研究(CLSA;n=24073)的中年和老年人参与者。英国生物库和 CLSA 的参与者分别随访了 8 年和 3 年。在基线时被诊断患有青光眼或 AMD 的参与者被排除在分析之外。在英国生物库中,通过住院入院、初级保健记录和自我报告的数据来确定睡眠呼吸暂停和青光眼和 AMD 的发病情况。多变量 Cox 比例风险模型用于探讨睡眠呼吸暂停与青光眼或 AMD 发病的关联。

结果

在英国生物库的 8 年随访期间,有睡眠呼吸暂停的参与者的青光眼发病率为每 1000 人年 2.46,无睡眠呼吸暂停的参与者为 1.59;有睡眠呼吸暂停的参与者的 AMD 发病率为每 1000 人年 2.27,无睡眠呼吸暂停的参与者为 1.42。多变量调整后,与无睡眠呼吸暂停的参与者相比,睡眠呼吸暂停与青光眼和 AMD 风险的相关性的风险比分别为 1.33(95%置信区间[CI] 1.10-1.60,P=0.003)和 1.39(95%CI 1.15-1.68,P<0.001)。在 CLSA 队列中,通过面对面访谈问卷收集疾病信息。在 3 年随访期间,有睡眠呼吸暂停和无睡眠呼吸暂停的参与者的青光眼发病率分别为每 1000 人年 9.31 和 6.97,AMD 发病率分别为每 1000 人年 8.44 和 6.67。在 CLSA 中,也发现了类似的关联,与无睡眠呼吸暂停的参与者相比,有睡眠呼吸暂停的参与者的青光眼和 AMD 比值比分别为 1.43(95%CI 1.13-1.79)和 1.39(95%CI 1.08-1.77)(均 P<0.001)。

结论

在两项大型前瞻性队列研究中,睡眠呼吸暂停与青光眼和 AMD 的风险增加相关。这些发现表明,患有睡眠呼吸暂停的患者可能受益于定期眼科检查。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c6ae/8111909/625f83d6a743/12916_2021_1973_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验